BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 16908914)

  • 1. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
    Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
    Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C as a risk factor for outcomes in chronic kidney disease.
    Menon V; Shlipak MG; Wang X; Coresh J; Greene T; Stevens L; Kusek JW; Beck GJ; Collins AJ; Levey AS; Sarnak MJ
    Ann Intern Med; 2007 Jul; 147(1):19-27. PubMed ID: 17606957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
    Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
    Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C concentration as a risk factor for heart failure in older adults.
    Sarnak MJ; Katz R; Stehman-Breen CO; Fried LF; Jenny NS; Psaty BM; Newman AB; Siscovick D; Shlipak MG;
    Ann Intern Med; 2005 Apr; 142(7):497-505. PubMed ID: 15809461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.
    Stevens LA; Coresh J; Schmid CH; Feldman HI; Froissart M; Kusek J; Rossert J; Van Lente F; Bruce RD; Zhang YL; Greene T; Levey AS
    Am J Kidney Dis; 2008 Mar; 51(3):395-406. PubMed ID: 18295055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C and the risk of death and cardiovascular events among elderly persons.
    Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
    N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Whooley MA
    Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    He J; Shlipak M; Anderson A; Roy JA; Feldman HI; Kallem RR; Kanthety R; Kusek JW; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Wolf M; Zhang X; Raj D; Hamm L;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
    Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
    JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
    Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
    Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    ; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT
    JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
    Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
    Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased kidney function in the elderly: clinical and preclinical, neither benign.
    Coresh J; Astor B
    Ann Intern Med; 2006 Aug; 145(4):299-301. PubMed ID: 16908921
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney function as a predictor of noncardiovascular mortality.
    Fried LF; Katz R; Sarnak MJ; Shlipak MG; Chaves PH; Jenny NS; Stehman-Breen C; Gillen D; Bleyer AJ; Hirsch C; Siscovick D; Newman AB
    J Am Soc Nephrol; 2005 Dec; 16(12):3728-35. PubMed ID: 16251239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods.
    White C; Akbari A; Hussain N; Dinh L; Filler G; Lepage N; Knoll GA
    J Am Soc Nephrol; 2005 Dec; 16(12):3763-70. PubMed ID: 16236805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
    Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
    J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
    Ng DK; Schwartz GJ; Warady BA; Furth SL; Muñoz A
    Am J Kidney Dis; 2017 Sep; 70(3):397-405. PubMed ID: 28549535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.